OrganoLab has established and validated a scalable process for the expansion of organoids without historical limitations.
Our organ-on-a-chip solutions provide innovative methods for culturing cells and tissues, while offering precise and continuous control during the entire culturing process.
Organoids possess the ability to self-assemble, self-renew, and differentiate, ranging in size from micrometer to millimeter scale, which may overcome the limitations of conventional cell culture systems.
OrganoLab has developed and validated the organoid models as screening tools to predict hepatoxicity, cardiotoxicity, gastrointestinal toxicity, and nephrotoxicity
Patient-derived and disease-specific organoids to model human pathophysiology, enabling drug screening, toxicity studies, and precision medicine research.
High-quality cryopreserved normal organoids with ready-to-use viability and reproducible function for drug discovery, disease modeling, and 3D tissue research.
Creative Bioarray’s advanced 3D tissue and organ-on-chip platforms replicate human organ physiology for predictive drug testing, disease modeling, and functional tissue studies.
Multiorgan-on-a-chip platforms simulate organ-organ interactions, supporting complex drug screening, pharmacokinetics studies, and integrated human-relevant research.
Comprehensive organoid culture reagents and tools for maintaining, expanding, and analyzing 3D organoid models with reproducible performance and high viability.
Tel:
Fax:
Email:
Interested in our Service & Products? Need detailed information?
Please contact us if you have questions about our company, our products, or general enquiries.
Please use the form below.
